Su‐Fang Lin
Impact in
- Oncology top 1%
- Viral-associated cancers and disorders
- Epidemiology top 1%
- Cytomegalovirus and herpesvirus research
- Herpesvirus Infections and Treatments
Papers in
- Oncology 45
- Viral-associated cancers and disorders 38
- Cancer Cells and Metastasis 3
-
- Parvovirus B19 Infection Studies 14
- Co-authors
- Dan R. RobinsonYi‐Mi WuRen SunGeorge MillerLyndle GradovilleYan YuanFanxiu ZhuHsing-Jien Kung
- Journals
- Journal of Virology (15 papers)Virology (5 papers)PLoS ONE (4 papers)Cancers (3 papers)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Su‐Fang Lin
60 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Oncology 2.2k
- Epidemiology 1.8k
- Infectious Diseases 466
- Virology 111
- Immunology 480
Countries citing papers authored by Su‐Fang Lin
This map shows the geographic impact of Su‐Fang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐Fang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐Fang Lin more than expected).
Fields of papers citing papers by Su‐Fang Lin
This network shows the impact of papers produced by Su‐Fang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐Fang Lin. The network helps show where Su‐Fang Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Su‐Fang Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 2 | |
| 6 | 2021 | 8 | |
| 7 | 2020 | 23 | |
| 8 | 2019 | 63 | |
| 9 | 2016 | 47 | |
| 10 | 2016 | 50 | |
| 11 | 2014 | 15 | |
| 12 | 2013 | 40 | |
| 13 | 2012 | 52 | |
| 14 | 2012 | 14 | |
| 15 | 2011 | 15 | |
| 16 | 2010 | 8 | |
| 17 | 2000 | 14 | |
| 18 | The protein tyrosine kinase family of the human genome Hit paper breakdown → | 2000 | 830 |
| 19 | 1998 | 69 | |
| 20 | 1998 | 7 |
About Su‐Fang Lin
Su‐Fang Lin is a scholar working on Oncology, Infectious Diseases, Epidemiology, Virology and Immunology and Allergy, having authored 60 papers that have together received 3.6k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (38 papers), Cytomegalovirus and herpesvirus research (26 papers), Parvovirus B19 Infection Studies (14 papers), Herpesvirus Infections and Treatments (10 papers), Histiocytic Disorders and Treatments (7 papers), Immune Cell Function and Interaction (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Oncology (2.2k citations), Epidemiology (1.8k citations), Infectious Diseases (466 citations), Virology (111 citations) and Immunology (480 citations). Su‐Fang Lin has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Dan R. Robinson, Yi‐Mi Wu, Ren Sun, George Miller, Lyndle Gradoville, Yan Yuan, Fanxiu Zhu, Hsing-Jien Kung, Elizabeth Grogan and Katherine Staskus. Their work appears in journals such as Journal of Virology, Virology, PLoS ONE, Cancers and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.